MICROLAX BEBE SORBITOL CITRATE and LAURILSULFOACETATE DE SODIUM, rectal solution in a single-dose container 4 single-dose containers of 3.87 g
Brand page: Microlax (sodium citrate + sodium laurylsulfoacetate + sorbitol) — all forms and strengths in France
Active ingredients: Sodium citrate, Sodium lauryl sulfoacetate, SORBITOL LIQUIDE (CRISTALLISABLE)
Commercialized according to BDPM
Solution4 single-dose containers of 3.87 grectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MICROLAX BEBE SORBITOL CITRATE ET LAURILSULFOACETATE DE SODIUM, solution rectale en récipient unidose
- Pharmaceutical form
- solution
- Route of administration
- rectale
- Presentation description
- 4 récipient(s) unidose(s) polyéthylène de 3,87 g avec canule(s)
- Marketing authorisation holder
- KENVUE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Sept 2002
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67367270CIP73544545CIP133400935445452Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (CITRATE DE)solution | 0,2700 g · un récipent unidose | SA |
| SODIUM (LAURILSULFOACÉTATE DE)solution | 0,0387 g de laurilsulfoacétate à 70 % · un récipent unidose | SA |
| SORBITOL LIQUIDE (CRISTALLISABLE)solution | 2,6790 g · un récipent unidose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.